Sharps Compliance Corp., a full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, has appointed Susan Vogt to its board of directors. Vogt replaces F. Gardner Parker who has resigned his board membership.
Vogt has over 35 years of experience in the global life science, pharmaceutical, biotech and clinical diagnostics markets in corporate leadership roles as well as serving on the board of directors for several public and private companies in the industry.
She currently serves as an independent director and member of the audit committee for Anika Therapeutics and previously served as a non-executive director and chair of the audit committee for UK-based Tap Biosystems and as a non-executive director and member of the remuneration and nomination committees for Andor Technology, PLC (LSE: AND). Additionally, she has served as an independent director and member of the audit committee for Justrite Manufacturing.
Vogt’s corporate leadership experience includes serving as chief executive officer and director of Aushon Biosystems, Inc., a biosciences company which was acquired by Quanterix Corporation in January 2018. Prior to that, Vogt served as president, chief executive officer and director of Seracare Life Sciences, Inc. Vogt began her career at Millipore Corporation, a multinational bioscience company.
During Vogt’s 24 years at Millipore, she held positions of increasing responsibility, culminating in the role of president of the Bio Pharmaceutical Division, a $520 million division with more than 1,600 employees across 23 countries, serving customers in the biotech, pharmaceutical and beverage manufacturing industries.
Published in the November 2019 Edition
